FN1 and VEGFA Are Potential Therapeutic Targets in Glioblastoma as Determined by Bioinformatics Analysis
Cancer Genomics - Proteomics · 2025-01 · 22 (1) · 70-80
DOI: 10.21873/cgp.20488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 27.12.2024. Verfasst von Mijung Im und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science Education, Korea National University of Education, Cheongju-si, Republic of Korea. Hauptthemen laut MEDLINE: Glioblastoma, Computational Biology, Vascular Endothelial Growth Factor A, Fibronectins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science Education, Korea National University of Education, Cheongju-si, Republic of Korea.
- Department of Biology Education, Seowon University, Cheongju-si, Republic of Korea.
- Department of Science Education, Korea National University of Education, Cheongju-si, Republic of Korea; wykim82@knue.ac.kr.
- Department of Biology Education, Korea National University of Education, Cheongju-si, Republic of Korea.
Zitieren
APA
Im, M., Roh, J., Jang, W., & Kim, W. (2025). FN1 and VEGFA Are Potential Therapeutic Targets in Glioblastoma as Determined by Bioinformatics Analysis. Cancer Genomics - Proteomics, 22(1), 70-80. https://doi.org/10.21873/cgp.20488
Vancouver
Im M, Roh J, Jang W, Kim W. FN1 and VEGFA Are Potential Therapeutic Targets in Glioblastoma as Determined by Bioinformatics Analysis. Cancer Genomics - Proteomics. 2025;22(1):70-80. doi:10.21873/cgp.20488
BibTeX
@article{Im2025,
author = {Im, Mijung and Roh, Jungwook and Jang, Wonyi and Kim, Wanyeon},
title = {FN1 and VEGFA Are Potential Therapeutic Targets in Glioblastoma as Determined by Bioinformatics Analysis},
journal = {Cancer Genomics - Proteomics},
year = {2025},
volume = {22},
number = {1},
pages = {70--80},
doi = {10.21873/cgp.20488}
}
EUVIMED